Close
Adolfo "Enrique" Diaz Duque, MD, MS
NOTE : If you're an existing patient, please connect via MyChart
-
About Me
About Adolfo "Enrique" Diaz Duque, MD, MS
Enrique Diaz, MD, is an associate professor in the Division of Hematology and Oncology at The University of Texas Health Science Center at San Antonio and leader of the adult lymphoma program at Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center.
He completed his medical training at the Pontificia Universidad Javeriana in Colombia and his internal medicine residency at New York University. He received his fellowship training in hematology-oncology and received a Master of Science degree in Clinical Investigation and Translational Science from The University of Texas Health Science Center San Antonio.
His research and clinical interests focus on improving outcomes in patients with lymphomas and health care disparities. He currently serves as an Ambassador for the American Society of Hematology.
Now enrolling patients in the following study:
Gender
- Male
Languages Spoken
- Spanish
-
Credentials
Credentials
Positions
- Associate Professor, Division on Hematology and Oncology, University of Texas Health Science Center San Antonio
Certifications
- American Board of Internal Medicine, Hematology
- American Board of Internal Medicine, Medical Oncology
Education
- Medical School: Pontificia Universidad Javeriana, Bogota, Colombia
- Fellowship: Hematology-Oncology, University of Texas Health Science Center San Antonio, San Antonio, TX
- Residency: New York University, New York, NY
- Internship: New York University, New York, NY
- Graduate: MS, Clinical Investigation and Translational Science, University of Texas Health Science Center San Antonio, San Antonio, TX
-
Locations & Contact
Locations & Contact
I really appreciate that every time I visit Dr. Diaz he knows my circumstances and has a plan for me.
Patient
-
Research & Publications
Research & Publications
Impact of Co-Morbidities on Outcome in a Predominantly Hispanic Population of Hodgkin and Non-Hodgkin Lymphoma Patients
Michelle Janania Martinez, MD, Juan F Garza, MD, Tyler W Snedden, MD, Prathibha Surapaneni, MD, Snegha Ananth, MBBS, Jeremy Rawlings, MD, David J Gregorio, DO, Sushanth Kakarla, MD, Qianqian Liu, PhD, Joel E Michalek, PhD, Adolfo Enrique Diaz, MD
Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma
William Kelly, Adolfo Enrique Diaz Duque, Joel Michalek, Brandon Konkel, Laura Caflisch, Yidong Chen, Sarath Chand Pathuri, Vinu Madhusudanannair-Kunnuparampil, John Floyd, Andrew Brenner
A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia
Iman Abou Dalle, Jorge E. Cortes, Pramod Pinnamaneni, Betty Lamothe, Adolfo Diaz Duque, Jasleen Randhawa, Naveen Pemmaraju, Elias Jabbour, Alessandra Ferrajoli, William G. Wierda, Zeev Estrov, Marina Konopleva, Farhad Ravandi, Yesid Alvarado, Gautam Borth
- Clinical Trials